Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| 1 |
Ferguson
FERG
|
+$962M |
| 2 |
GE Vernova
GEV
|
+$538M |
| 3 |
Exxon Mobil
XOM
|
+$470M |
| 4 |
ResMed
RMD
|
+$375M |
| 5 |
International Paper
IP
|
+$351M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$1.08B |
| 2 |
Microsoft
MSFT
|
+$738M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$558M |
| 4 |
Apple
AAPL
|
+$412M |
| 5 |
AbbVie
ABBV
|
+$395M |
Sector Composition
| 1 | Technology | 28.34% |
| 2 | Healthcare | 11.75% |
| 3 | Financials | 11.44% |
| 4 | Consumer Discretionary | 9.24% |
| 5 | Industrials | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3351
CorMedix
CRMD
$955M
| $688K | ﹤0.01% |
158,901
+25,677
| +19% | +$111K |
|
3352
Mistras Group
MG
$301M
| $688K | ﹤0.01% |
82,988
+10,046
| +14% | +$83.3K |
|
|
LENZ
3353
LENZ Therapeutics
LENZ
$1.19B
| $687K | ﹤0.01% |
39,737
+28,556
| +255% | +$494K |
|
3354
The Joint Corp
JYNT
$157M
| $686K | ﹤0.01% |
48,791
-1,394
| -3% | -$19.6K |
|
3355
Real Estate Select Sector SPDR Fund
XLRE
$7.72B
| $686K | ﹤0.01% |
17,854
-564
| -3% | -$21.7K |
|
3356
John Marshall Bancorp
JMSB
$286M
| $685K | ﹤0.01% |
39,265
+6,411
| +20% | +$112K |
|
3357
Nektar Therapeutics
NKTR
$916M
| $684K | ﹤0.01% |
36,769
+35,511
| +2,823% | +$661K |
|
3358
Sight Sciences
SGHT
$179M
| $683K | ﹤0.01% |
102,461
+42,383
| +71% | +$283K |
|
3359
National Bankshares
NKSH
$194M
| $683K | ﹤0.01% |
24,156
+471
| +2% | +$13.3K |
|
3360
Potbelly
PBPB
$514M
| $683K | ﹤0.01% |
85,048
+7,012
| +9% | +$56.3K |
|
3361
TScan Therapeutics
TCRX
$104M
| $682K | ﹤0.01% |
+116,658
| New | +$682K |
|
3362
Everspin Technologies
MRAM
$154M
| $681K | ﹤0.01% |
113,655
+49,032
| +76% | +$294K |
|
3363
Holley
HLLY
$360M
| $679K | ﹤0.01% |
189,715
+1,769
| +0.9% | +$6.33K |
|
3364
MPLX
MPLX
$50.8B
| $678K | ﹤0.01% |
15,925
+1,670
| +12% | +$71.1K |
|
3365
Dave Inc
DAVE
$2.89B
| $677K | ﹤0.01% |
+22,357
| New | +$677K |
|
3366
Blue Foundry Bancorp
BLFY
$200M
| $677K | ﹤0.01% |
74,637
+9,303
| +14% | +$84.4K |
|
3367
QuickLogic
QUIK
$86.6M
| $676K | ﹤0.01% |
65,061
+38,273
| +143% | +$398K |
|
3368
Lexicon Pharmaceuticals
LXRX
$392M
| $675K | ﹤0.01% |
401,908
+109,902
| +38% | +$185K |
|
3369
Concrete Pumping Holdings
BBCP
$366M
| $675K | ﹤0.01% |
112,341
+12,855
| +13% | +$77.3K |
|
|
BLUE
3370
DELISTED
bluebird bio
BLUE
| $675K | ﹤0.01% |
34,288
+5,579
| +19% | +$110K |
|
3371
Coherus Oncology, Inc. Common Stock
CHRS
$152M
| $673K | ﹤0.01% |
389,225
+80,222
| +26% | +$139K |
|
3372
Viking Holdings
VIK
$27.9B
| $670K | ﹤0.01% |
+19,745
| New | +$670K |
|
3373
The Beauty Health Co
SKIN
$292M
| $668K | ﹤0.01% |
348,108
+69,329
| +25% | +$133K |
|
|
PSTX
3374
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $668K | ﹤0.01% |
228,700
+26,316
| +13% | +$76.8K |
|
3375
Precigen
PGEN
$1.22B
| $666K | ﹤0.01% |
421,788
+19,301
| +5% | +$30.5K |
|